#news #biotech Backers put $12.7M behind Enterin’s Parkinson’s disease approach

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Backers put $12.7M behind Enterin’s Parkinson’s disease approach .Philadelphia biotech Enterin has raised $12.7 million in funding to pursue its hypothesis that the origins of Parkinson’s disease start in the gut, not the brain.

from FierceBiotech: Biotech http://ift.tt/2uuYKff